Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT06811311

EEG Study on Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy in Generalized Anxiety Disorder

Led by Uskudar University · Updated on 2025-02-20

60

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

Sponsors

U

Uskudar University

Lead Sponsor

I

Istanbul Nisantasi University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study examines the neurophysiological and psychological effects of Ericksonian hypnotherapy in individuals diagnosed with Generalized Anxiety Disorder (GAD). Using electroencephalography (EEG), the study aims to assess changes in brain activity and anxiety symptoms before and after treatment. A total of 60 participants will be recruited from both governmental and private psychiatric clinics in Istanbul. Participants will be randomly assigned to either the intervention group (receiving 12 Ericksonian hypnotherapy sessions over 12 weeks) or the control group (receiving no intervention). The primary outcome measures include changes in EEG patterns, specifically alpha, theta, and frontal asymmetry indices, and changes in anxiety severity, measured by the Beck Anxiety Inventory (BAI), Generalized Anxiety Disorder-7 (GAD-7), and State-Trait Anxiety Inventory (STAI). Secondary measures include emotional regulation (DERS) and quality of life (WHOQOL-BREF). This study aims to provide scientific evidence on the effectiveness of Ericksonian hypnotherapy as a complementary treatment for GAD and its impact on brain function and emotional well-being.

CONDITIONS

Official Title

EEG Study on Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy in Generalized Anxiety Disorder

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Generalized Anxiety Disorder (GAD) based on DSM-5 criteria
  • Aged 18-65 years
  • Capable of providing written informed consent
  • Fluent in Turkish (for hypnosis and assessments)
  • Not currently receiving psychotherapy or pharmacological treatment for anxiety
Not Eligible

You will not qualify if you...

  • Presence of comorbid psychiatric disorders (e.g., schizophrenia, bipolar disorder, major depression requiring immediate intervention)
  • History of neurological conditions (e.g., epilepsy, traumatic brain injury, stroke)
  • Current use of medications affecting EEG activity (e.g., benzodiazepines, SSRIs, antipsychotics)
  • Previous experience with hypnotherapy (to avoid expectancy bias)
  • Substance abuse or dependence within the last six months
  • Pregnancy or breastfeeding
  • Severe medical conditions that may interfere with participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Üsküdar University, Neuro-Psychology Lab

Istanbul, Turkey (Türkiye), 34277

Actively Recruiting

Loading map...

Research Team

S

Selami Varol Ülker, Phd

CONTACT

M

Metin Çınaroğlu, Phd

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here